GSK (LSE:GSK) recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Extreme stock market volatility will inevitably prompt some income investors to declare that “cash is king”. After all, cash ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Biotech has been hard hit, as one might expect, leaving many names in bargain territory. Learn why there are opportunities amidst market volatility.

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

could cause cancer were “admissible”, sparking a sell-off in GSK shares that wiped billions off its market cap. Now, the drugmaker and co-defendants, including Pfizer, Sanofi, and Boehringer ...

When pressed for 2025 expectations, Verona believed $254 million in revenues was a fair estimate. Critically, Verona expects ...

GSK sits in the top ten with a £55bn market cap, with Hikma Pharmaceuticals, a smaller outfit at £4.2bn, but still in the top 100 listed companies in the UK. The three firms have seen their ...

GSK market cap is currently £59.69B and has a P/E ratio of 23.26. Based on the recent corporate insider activity of 311 insiders, corporate insider sentiment is negative on the stock. This means ...

In this article, we are going to take a look at where GSK ... the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap ...